Association Between Inpatient Medication Treatment for Opioid Use Disorder and Reduced One-Year All-Cause Mortality in Patients With Invasive Bacterial Infections - Top-Institutions - MDSpire

Association Between Inpatient Medication Treatment for Opioid Use Disorder and Reduced One-Year All-Cause Mortality in Patients With Invasive Bacterial Infections

  • By

  • Nicholas J Blair

  • Adam Kopp

  • Christine Kubin

  • Jesse Cotton

  • Michael T Yin

  • Matthew Scherer

  • February 3, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Addiction Medicine
    • Hospital Medicine

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Addiction Psychiatry
    • Internal Medicine

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Addiction Medicine
    • Public Health

  • #4

    Washington University in St. Louis
    Washington University in St. Louis

    St. Louis, MO

    Key Differentiators

    • Infectious Diseases
    • Addiction Medicine
    • Internal Medicine

  • #5

    Yale University
    Yale University

    New Haven, CT

    Key Differentiators

    • Infectious Diseases
    • Addiction Medicine
    • Epidemiology

Original Source(s)

Association Between Inpatient Medication Treatment for Opioid Use Disorder and Reduced One-Year All-Cause Mortality in Patients With Invasive Bacterial Infections

  • by Nicholas J Blair, Adam Kopp, Christine Kubin, Jesse Cotton, Michael T Yin, Matthew Scherer

  • February 3, 2025

Related Content

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

Trump administration’s drug strategy is at odds with recent actions on funding, policy

Timely Receipt of New Medication Treatment After Acute Care Encounters for Opioid Overdose in the U.S. Medicaid Population